Kohn JE, et al. - Researchers here perform a comparison of one-year continuation of subcutaneous depot medroxyprogesterone acetate (DMPA-sc) between women randomized to self-administration vs clinic administration. Observations reveal that self-administration of subcutaneous DMPA improves contraceptive continuation and is a feasible and acceptable option for women and adolescents